Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.11.2011 | Case report

Bevacizumab

Anastomotic dehiscence in an elderly patient: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Eveno C, Soyer P, Teixeira L, Staudacher L, Pocard M.Anastomotic dehiscence during treatment with bevacizumab 5 years after colo-anal anastomosis with proposition for management without stopping chemotherapy. Clinics and Research in Hepatology and Gastroenterology 35: 594-596, No. 89, Sep 2011. Available from: URL: http://dx.doi.org/10.1016/j.clinre.2011.04.011 - France Eveno C, Soyer P, Teixeira L, Staudacher L, Pocard M.Anastomotic dehiscence during treatment with bevacizumab 5 years after colo-anal anastomosis with proposition for management without stopping chemotherapy. Clinics and Research in Hepatology and Gastroenterology 35: 594-596, No. 89, Sep 2011. Available from: URL: http://​dx.​doi.​org/​10.​1016/​j.​clinre.​2011.​04.​011 - France
Metadaten
Titel
Bevacizumab
Anastomotic dehiscence in an elderly patient: case report
Publikationsdatum
01.11.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113760-00027

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Lithium

Case report

Tacrolimus

Case report

Ritodrine